Hypertension

35 competing products in clinical development for Hypertension.

Pipeline by Phase

Pre-clinical3

Phase 19

Phase 21

Phase 2/31

Phase 37

Approved14

All Products (35)

Product	Company	Stage	Status	Hype
Amlodipine + Valsartan	Yuhan	Approved	Completed	43
Duowell® + Telmisartan	Yuhan	Approved	Completed	43
Olmesartan medoxomil + Losartan potassium + Atenolol	Daiichi Sankyo	Approved	Completed	43
olmesartan medoxomil + hydrochlorothiazide, if necessary + Placebo	Daiichi Sankyo	Approved	Completed	43
olmesartan medoxomil and a CCB + olmesartan medoxomil and a diuretic	Daiichi Sankyo	Approved	Completed	43
Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + Hydrochlorothiazide	Daiichi Sankyo	Approved	Completed	43
olmesartan medoxomil + Placebo + losartan potassium	Daiichi Sankyo	Approved	Completed	43
amlodipine and olmesartan medoxomil tablets + hydrochlorothiazide tablets	Daiichi Sankyo	Approved	Completed	43
Perindopril + amlodipine + if necessary, hydrochlorothiazide + olmesartan/amlodipine + hydrochlorothiazide, if necessary.	Daiichi Sankyo	Approved	Completed	43
Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide	Daiichi Sankyo	Approved	Completed	43
Olmesartan medoxomil + Hydroclorothiazide + Benazepril + Amlodipine	Daiichi Sankyo	Approved	Completed	43
olmesartan medoxomil + Olmesartan medoxomil plus Hydrochlorothiazide	Daiichi Sankyo	Approved	Completed	43
SEVIKAR	Daiichi Sankyo	Approved	Completed	43
olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure + atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure	Daiichi Sankyo	Approved	Completed	43
Temisartan+Amlodipine+Rosuvastatin (Combination drug) + Temisartan+Amlodipine + Temisartan+Rosuvastatin	Yuhan	Phase 3	Completed	40
OM 40 + OM/HCTZ 40/12.5	Daiichi Sankyo	Phase 3	Completed	40
telmisartan/amlodipine 40/5mg + YH22162 40/5/12.5 mg + telmisartan/amlodipine 80/5mg + YH22162 80/5/25 mg + telmisartan/amlodipine 40/5mg placebo + YH22162 40/5/12.5 mg placebo + telmisartan/amlodipine 80/5mg placebo + YH22162 80/5/25 mg placebo	Yuhan	Phase 3	Completed	40
Olmesartan medoxomil + Amlodipine + Hydrochlorothiazide	Daiichi Sankyo	Phase 3	Completed	40
CS-3150	Daiichi Sankyo	Phase 3	Completed	40
Amlodipine + Olmesartan medoxomil plus amlodipine	Daiichi Sankyo	Phase 3	Completed	40
Olmesartan medoxomil + Amlodipine	Daiichi Sankyo	Phase 3	Completed	40
olmesartan medoxomil + placebo + olmesartan medoxomil	Daiichi Sankyo	Phase 2/3	Completed	38
CS-3150	Daiichi Sankyo	Phase 2	Completed	35
Telmisartan + Amlodipine + Chlorthalidone	Yuhan	Phase 1	Completed	29
Temisartan/Amlodipine+Rosuvastatin + YHP1604	Yuhan	Phase 1	Completed	29
Rosuvastatin+Valsartan (Sequence 1) + Rosuvastatin+Valsartan (Sequence 2) + Rosuvastatin+Valsartan (Sequence 3) + Rosuvastatin+Valsartan (Sequence 4) + Rosuvastatin+Valsartan (Sequence 5) + Rosuvastatin+Valsartan (Sequence 6)	Yuhan	Phase 1	Completed	29
Twynsta 80/5mg + Crestor 20mg	Yuhan	Phase 1	Completed	29
Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg + Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg	Yuhan	Phase 1	Completed	29
YH22162 + Telmisartan/Amlodipine 80/5 mg (FDC) + Chlorthalidone 25mg	Yuhan	Phase 1	Completed	29
CS-3150 + Moxifloxacin + Placebo matching moxifloxacin tablet + Placebo matching CS-3150	Daiichi Sankyo	Phase 1	Completed	29
Olmesartan medoxomil	Daiichi Sankyo	Phase 1	Completed	29
Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg	Yuhan	Pre-clinical	Completed	26
olmesartan, hydrochlorothiazide, amlodipine + hydrochlorothiazide (HCTZ) or olmesartan	Daiichi Sankyo	Pre-clinical	Completed	26
Telmisartan 80mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg	Astellas Pharma	Pre-clinical	Completed	26
YH22189 + Twynsta 80/10mg + Crestor 20mg	Yuhan	Phase 1	Terminated	21